NCT06971458 Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol
| NCT ID | NCT06971458 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hillel Yaffe Medical Center |
| Condition | IVF |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2022-08-09 |
| Primary Completion | 2027-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility. Endometriomas are most commonly treated either medically or by surgical excision. Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.
Eligibility Criteria
Inclusion Criteria: A woman with endometrioma with a diameter of 25-100 mm Exclusion Criteria: * Other causes of infertility (sperm disorder, ovulation disorder, uterine disorder, mechanical factor, poor ovarian reserve)